A pregnant client presents to the prenatal clinic with flu-like symptoms. Laboratory results reveal positive IgM antibodies for cytomegalovirus (CMV). What is the most important assessment the nurse should prioritize for this client?

Primary CMV infection during pregnancy risks fetal neurological complications and growth restriction. Ultrasound assessment is prioritized to evaluate fetal well-being. Other options focus on maternal conditions less directly linked to CMV risks.

Understanding the Clinical Scenario

The client’s presentation includes persistent headache, photophobia, and neck stiffness following exposure to meningitis, combined with laboratory-confirmed primary cytomegalovirus (CMV) infection (positive IgM). While the neurological symptoms raise immediate concern for meningitis, the question specifically asks for the priority assessment related to the confirmed CMV infection in the context of pregnancy. The core of this question tests the nurse's ability to prioritize care based on the most significant risk to the fetus following a primary maternal CMV infection.

Why Fetal Growth and Development Assessment is the Priority

The correct answer is to evaluate fetal growth and development through ultrasound. The primary concern with a primary CMV infection during pregnancy is vertical transmission to the fetus, leading to congenital cytomegalovirus (cCMV) infection. This is the most common congenital infection globally and a leading cause of preventable childhood disability [1,2]. The virus can cross the placenta, and the resulting fetal infection can directly impact organogenesis and growth, leading to a spectrum of adverse outcomes.

The rationale for prioritizing an ultrasound is directly supported by the provided evidence. A study on antenatal imaging in cCMV confirms that standardized prenatal care for women with primary CMV infection includes serial ultrasound examinations to monitor for fetal abnormalities ^[4]. These abnormalities are not limited to one system; they can include central nervous system (CNS) findings, such as ventriculomegaly or intracranial calcifications, which correlate with the neurodevelopmental sequelae mentioned in the literature ^[1]. Furthermore, CMV infection can cause fetal growth restriction, hepatosplenomegaly, and echogenic bowel, all of which are detectable via ultrasound. The ultrasound findings provide crucial prognostic information and guide further management, such as consideration for antiviral therapy or amniocentesis ^[4].

Analyzing the Incorrect Options

While the other assessments are important in general prenatal care, they do not directly address the primary pathophysiological threat posed by a new CMV infection.

- Option 1: Assess for signs of preterm labor contractions. While systemic maternal infection can sometimes trigger preterm labor, it is not the most direct or specific complication of CMV. The immediate and defining risk is fetal infection and its teratogenic effects, not the secondary risk of preterm birth. The studies highlight neurodevelopmental and audiological sequelae, not prematurity, as the hallmark of cCMV ^[1].

- Option 2: Monitor maternal blood pressure and proteinuria. This assessment is specific to screening for preeclampsia. Although the client’s headache could be a symptom of severe preeclampsia, her report of photophobia, neck stiffness, and known exposure to meningitis makes a CNS infection a more likely cause of her neurological symptoms than preeclampsia. More importantly, this assessment does not address the newly diagnosed CMV infection, which is the focus of the question.

- Option 4: Check for cervical dilation and effacement. This assessment is used to diagnose preterm labor or evaluate for cervical insufficiency. At 32 weeks gestation, this is a general assessment but is not the priority related to the specific finding of a primary CMV infection. The immediate threat is not the initiation of labor but the ongoing damage the virus can inflict on the developing fetus in utero.

Clinical Management and Nursing Implications

The detection of positive CMV IgM antibodies during pregnancy should prompt immediate referral to a maternal-fetal medicine or infectious diseases specialist ^[2]. The nurse’s role is to facilitate this referral and prioritize assessments that screen for fetal impact. Serial ultrasound examinations are a cornerstone of this evaluation to detect structural abnormalities and growth restriction ^[4]. Antenatal treatment with high-dose valaciclovir has been shown to reduce the risk of in utero transmission, particularly after a first-trimester primary infection, making early and accurate diagnosis of fetal involvement critical [2,4]. The presence or absence of sonographic findings is a key predictor of adverse neonatal outcomes, as the extent of fetal damage directly correlates with long-term prognosis ^[1].